openPR Logo
Press release

Chronic Disease Management Market :- Wellcentive, Medecision, i2i Systems, HealthSmart Holdings

11-08-2019 11:14 AM CET | IT, New Media & Software

Press release from: Data Bridge Market Research

/ PR Agency: Data Bridge Market Research
Chronic Disease Management Market

Chronic Disease Management Market

This Chronic Disease Management Market report involves critical parts of the Chronic Disease Management Market that contains industry inquire about, market estimating and conjecture, focused knowledge, advertise passage system, valuing patterns, manageability patterns, client bits of knowledge, innovation development, advancement patterns, and appropriation channel evaluation. Chronic Disease Management Market report mulls over key market elements of division. With this report, organizations can consider the scene about how the market is going to follow up on in the estimate a long time by picking up subtleties on market definition, arrangements, applications, and commitment.

Global Chronic disease management market is expected to rise to an estimated value of USD 14.80 billion by 2026, registering a healthy CAGR in the forecast period of 2019-2026. This rise in market value can be attributed to the increasing levels of geriatric population resulting in higher prevalence of chronic diseases in patients globally along with the advancement in technologies associated with medical devices.

Sample PDF Report Is Ready | Ask For More : https://databridgemarketresearch.com/request-a-sample/?dbmr=global-chronic-disease-management-market

Market Definition: Global Chronic Disease Management Market

Chronic disease management is digital healthcare services that include in providing healthcare officials with educational insights to their patients, implementation of patient-specific and disease-specific treatment options and plans. These services are specifically designed for managing the chronic diseases and reducing their severity in patients.

Market Drivers

Increasing prevalence and awareness regarding the fatality of chronic diseases; this factor is expected to drive the growth of the market
Increasing levels of integration of digitalization in healthcare systems and facilities; this factor is expected to drive the growth of the market
Rise in the support provided by the governments for the adoption of technologies in healthcare management; this factor is expected to drive the market growth
Market Restraints

Restraint in adoption and obedience in following the treatment plants designed according to the need of their disease management; this factor is expected to restrain the growth of the market
Lack of technically skilled professionals and workforce required for the management and maintenance of these diseases; this factor is expected to restrain the market growth
Request for Detailed TOC: https://databridgemarketresearch.com/toc/?dbmr=global-chronic-disease-management-market

Segmentation: Global Chronic Disease Management Market

By Disease Type

Cardiovascular Diseases (CVD)
Diabetes
Cancer
Asthma
Chronic Obstructive Pulmonary Disorders (COPD)
Arthritis
Stroke
Others
By Service Type

Consulting Service
Implementation Service
Educational Services
Others
By Deployment Model

On-Premise
Cloud-Based
Web-Based
By End-User

Providers
Ambulatory Care Centers
Hospitals, Physician Groups & Integrated Delivery
Diagnostic & Imaging Centers
Home Healthcare Agencies, Nursing Homes & Assisted Living Facilities
Others
Payer
Public Payers
Private Payers
Others
By Geography

North America
S.
Canada
Mexico
South America
Brazil
Argentina
Rest of South America
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Turkey
Belgium
Netherlands
Switzerland
Rest of Europe
Asia-Pacific
Japan
China
South Korea
India
Australia
Singapore
Thailand
Malaysia
Indonesia
Philippines
Rest of Asia-Pacific
Middle East & Africa
South Africa
Egypt
Saudi Arabia
United Arab Emirates
Israel
Rest of Middle East & Africa
Key Developments in the Market:

In October 2018, cliexa, Inc. announced that they had acquired Preventive Technology Solutions Inc. (PTSI). This acquisition will help in the development and expansion of cliexa’s service offerings. cliexa, Inc. will focus on the development of health apps for primary care and family medicine physicians which are determining the risks in adolescent for sexual activities, abuse of substances and other issues.
In July 2016, HealthCare at home announced that they had acquired Health Impetus Pvt. Ltd, this acquisition is expected to provide HealthCare at home in providing disease management services as well as providing various services to the pharmaceutical industry.
Request Analyst Call On : https://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-chronic-disease-management-market

Competitive Analysis: Global Chronic Disease Management Market

Global chronic disease management market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of chronic disease management market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Competitors: Global Chronic Disease Management Market

Few of the major competitors currently working in the global chronic disease management market are Allscripts; ScienceSoft USA Corporation; Siemens Healthcare Private Limited; EXL; cliexa, Inc.; MINES & Associates, Inc.; Mediware Information Systems; Pegasystems Inc.; HealthCare atHOME; Cognizant TriZetto Software Group, Inc.; IBM Corporation; Infosys Limited; Koninklijke Philips N.V.; AxisPoint Health; Medecision; i2i Systems; Epic Systems Corporation and ZeOmega.

Customization With Discount Available | Ask For More https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-chronic-disease-management-market

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Corporatesales@databridgemarketresearch.com

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, South America, MEA, Europe or Asia | Mail us at sopan.gedam@databridgemarketresearch.com

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Chronic Disease Management Market :- Wellcentive, Medecision, i2i Systems, HealthSmart Holdings here

News-ID: 1863910 • Views:

More Releases from Data Bridge Market Research

Tomato Ketchup Market Size to Surpass USD 19.61 billion by 2029, Share, Growth, Demand, Global Trends, Challenges and Competitive Outlook
Tomato Ketchup Market Size to Surpass USD 19.61 billion by 2029, Share, Growth, …
A crucial source of information, the Tomato Ketchup Market Research Report provides approaching and current technological and financial aspects of the industry through 2030. For the benefit of readers and end users, all gathered market data is verified and confirmed by industry professionals. With the help of this reliable marketing report, analyzing the actions of major companies and their impact on sales, import, export, revenue, and CAGR numbers becomes simple. The
Nitrile Butadiene Rubber (NBR) Market Is Projected to Value at a CAGR of 7.68%, Globally, by 2029: States Data Bridge Market Research
Nitrile Butadiene Rubber (NBR) Market Is Projected to Value at a CAGR of 7.68%, …
The top-notch Nitrile Butadiene Rubber (NBR) Market study has been created to offer a thorough examination of the market structure as well as projections for the various market segments and sub-segments. The purpose of this market study is to provide a thorough analysis of the market structure as well as a forecast for the various market segments and sub-segments. Consumer needs in the global market have been analyzed by key regions,
Professional Footwear Market to Exhibit a Noteworthy Growth by 2029, Size, Share, Growth, Demand, Drivers, Revenue Forecast and Opportunity Analysis
Professional Footwear Market to Exhibit a Noteworthy Growth by 2029, Size, Share …
Professional Footwear Market is a comprehensive and expert report that emphasizes market share, leading segments, geographic analysis, and primary and secondary drivers. A market research study includes basic, secondary, and advanced data about the state and trends of the global market as well as its size, growth, share, and segmentation as well as forecasts for the years 2023 through 2030. The study serves as the best foundation for examining competitors, evaluating
Nanoparticles Market to Observe Utmost CAGR of 6.00% by 2029, Size, Share, Demand, Key Drivers, Development Trends and Competitive Outlook
Nanoparticles Market to Observe Utmost CAGR of 6.00% by 2029, Size, Share, Deman …
The Nanoparticles Market research study offers a quantitative assessment of the primary obstacles that the company is facing both now and in the future. The main components of this market study are the market analysis, market definition, currency and price, significant advancements, and market classification in addition to a thorough research methodology. This market report's market study looks at a number of market segments that are predicted to grow at the

All 5 Releases


More Releases for Chronic

Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Reviewed, …
Market Research Hub (MRH) has recently broadcasted a new study to its broad research portfolio, which is titled as “Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Review, H1, 2017”, provides an overview of Chronic Kidney Disease (Chronic Renal Failure) clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Kidney Disease (Chronic Renal Failure). Report includes an overview of trial numbers and
Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Market Res …
Latest industry research report on: Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts GlobalData's clinical trial report, Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Review, H1, 2017" provides an overview of Chronic Kidney Disease (Chronic Renal Failure) clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Kidney
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, T …
Orbisreserach.Com Adds “H1 Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Market Pipeline Review 2017 Trend Analysis Report Report” To Its Research Database Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2017, provides an overview of the Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) (Oncology) pipeline landscape. Chronic myeloid leukemia (CML), also known as chronic myelogenous leukemia, is a type of cancer that starts in the blood-forming cells of the
Boot chronic pain
For immediate release Due to our rushed lives and stressful environment, many people are suffering from chronic pain and fatigue. We feel permanently tired and are barely able to get through our normal day. One is able to change this status when following the guidelines the book "Tired of being Tired to the point of being Gatvol (Fed Up). Some people will need a team of medical practitioners to help them
11-10-2016 | Health & Medicine
MRR.biz
Global Chronic, Acute, And Neuropathic Pain Market: Opioids To Remain Most Value …
The research report, titled “Frontier Pharma: Chronic, Acute And Neuropathic Pain - GPCR And Nerve Growth Factor-Based Therapies Offer Strong Potential In Difficult-To-Treat Subtypes,” analyzes the historical as well as the existing performance of this market, emphasizing specifically on various types of therapies applied to treat chronic, acute, and neuropathic pain. According to this 68-page study, the worldwide market for chronic, acute, and neuropathic pain has been observing a significant
Targeting chronic pain
With the support of the Austrian Science Fund FWF, the neurophysiologist Ruth Drdla-Schutting is investigating the role astrocytes play in the genesis of chronic pain. With the help of innovative gene technology (DREADDs), scientists are tailoring treatment specifically to these cells that are the most numerous found in the central nervous system. Pain is an important protection system of the human body. But when it becomes chronic, as it frequently